Table 1.

Different responses of KA, SCC and BCC to different treatment protocols

Variable	N	Overall	NR (n = 10)	RP (n = 4)	R (n = 21)	p value
			Mean ± SD
Age	35	79.57 ± 11.01	80.8 ± 11.05	75.5 ± 13.33	79.76 ± 10.96	0.590
Sex
Male	35	17.00	4 (0.24)	3 (0.18)	10 (0.59)	0.802
Female		18.00	6 (0.33)	1 (0.06)	11 (0.61)
Weeks	35	6.54 ± 2.84	5.5 ± 2.37	10 ± 5.83	6.38 ± 1.77	0.168
Diameter	35	3.6 ± 2.61	3.86 ± 3.49	6.5 ± 3	2.92 ± 1.6	0.433
No. of treatments	35	4.46 ± 2.15	3.4 ± 1.51	6.25 ± 1.5	4.62 ± 2.29	0.670
Cumulative dosage	35	133.29 ± 99.24	96.5 ± 67.78	198.75 ± 63.29	138.33 ± 111.86	0.442
Dosage for treatment	35	22.15 ± 15.6	20.93 ± 16.87	30 ± 23.18	21.23 ± 13.83	0.141
KT types
SCC	35	21.00	8 (0.38)	3 (0.14)	10 (0.48)	0.018
KA		12.00	0 (0)	1 (0.08)	11 (0.92)
BCC		2.00	2 (1)	0 (0)	0 (0)